{"title": "Johnson & Johnson inicia el ensayo cl\u00ednico de fase 3 de la candidata a la vacuna contra la COVID-19 de Janssen a nivel global", "author": null, "url": "https://www.prnewswire.com/news-releases/johnson-amp-johnson-inicia-el-ensayo-clinico-de-fase-3-de-la-candidata-a-la-vacuna-contra-la-covid-19-de-janssen-a-nivel-global-889733822.html", "hostname": "prnewswire.com", "description": "/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (la Empresa) anunci\u00f3 hoy el lanzamiento de su ensayo de fase 3 (ENSEMBLE) pivotal, a gran escala y para m\u00faltiples...", "sitename": "PR Newswire", "date": "2020-09-24", "id": null, "license": null, "body": null, "comments": "Share this article", "commentsbody": null, "raw_text": null, "text": "Johnson & Johnson inicia el ensayo cl\u00ednico de fase 3 de la candidata a la vacuna contra la COVID-19 de Janssen a nivel global\n[Johnson & Johnson](/news/johnson-%26-johnson/)\n24 Sep, 2020, 14:11 ET\n[]\nLos primeros participantes reciben la dosis en el ensayo de fase 3 (ENSEMBLE) que eval\u00faa la seguridad y eficacia de la candidata a la vacuna contra la COVID-19 de Janssen, JNJ-78436735, tambi\u00e9n conocida como Ad26.COV2.S\nNEW BRUNSWICK, Nueva Jersey, 24 de septiembre de 2020 /PRNewswire/ -- Johnson & Johnson (NYSE:\n[JNJ](#financial-modal)) (la Empresa) anunci\u00f3 hoy el lanzamiento de su ensayo de fase 3 (ENSEMBLE) pivotal, a gran escala y para m\u00faltiples pa\u00edses para su candidata a la vacuna contra la COVID-19, JNJ-78436735, que est\u00e1 siendo desarrollada por Janssen Pharmaceutical Companies. El inicio del ensayo ENSEMBLE sigue los resultados provisorios positivos del estudio cl\u00ednico de fase 1/2 de la Empresa, que demostraron que el perfil de seguridad y la inmunogenia despu\u00e9s de una sola dosis fueron alentadores para continuar su desarrollo. Estos resultados se han enviado a medRxiv y se publicar\u00e1n en l\u00ednea pr\u00f3ximamente. En funci\u00f3n de estos resultados y tras las conversaciones con la Administraci\u00f3n de Medicamentos y Alimentos (FDA) de EE. UU., ENSEMBLE reclutar\u00e1 un m\u00e1ximo de 60.000 voluntarios de tres continentes y estudiar\u00e1 la seguridad y eficacia de una sola dosis de la vacuna frente al placebo para prevenir la COVID-19.\nJohnson & Johnson ha seguido ampliando su capacidad de producci\u00f3n y contin\u00faa encaminada para lograr el objetivo de suministrar mil millones de dosis de una vacuna por a\u00f1o. La Empresa se compromete a suministrar una vacuna accesible al p\u00fablico sin fines de lucro para utilizarse con car\u00e1cter de emergencia en el marco de la pandemia; a su vez, anticipa los primeros lotes de una vacuna contra la COVID-19 a fin de que est\u00e9n disponibles para la autorizaci\u00f3n de su uso de emergencia a comienzos de 2021, en el caso de que resulte ser segura y eficaz.\nJohnson & Johnson desarrollar\u00e1 y evaluar\u00e1 su candidata a la vacuna contra la COVID-19 de acuerdo con altos est\u00e1ndares \u00e9ticos y s\u00f3lidos principios cient\u00edficos. La Empresa se compromete a ser transparente y a compartir informaci\u00f3n relacionada con el estudio ENSEMBLE de fase 3, incluso el\n[protocolo de estudio](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=1139456354&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1522581176%26u%3Dhttps%253A%252F%252Fwww.jnj.com%252Fcoronavirus%252Fcovid-19-phase-3-study-clinical-protocol%26a%3Dstudy%2Bprotocol&a=protocolo+de+estudio).\n\"Mientras la COVID-19 sigue afectando la vida cotidiana de las personas de todo el mundo, nuestro objetivo sigue siendo el mismo: aprovechar el alcance global y la innovaci\u00f3n cient\u00edfica de nuestra empresa para ayudar a terminar con esta pandemia\", expres\u00f3 Alex Gorsky, presidente y director ejecutivo, Johnson & Johnson. \"Al ser la empresa de cuidado de la salud m\u00e1s grande a nivel mundial, estamos aplicando nuestros mejores conocimientos cient\u00edficos y est\u00e1ndares rigurosos de seguridad, en colaboraci\u00f3n con las autoridades reguladoras, a fin de agilizar la lucha contra esta pandemia. Este hito fundamental demuestra nuestros esfuerzos enfocados en una vacuna contra la COVID-19, que se logran gracias a la colaboraci\u00f3n y al profundo compromiso con un s\u00f3lido proceso cient\u00edfico. Nos comprometemos a ofrecer transparencia en el ensayo cl\u00ednico y a compartir informaci\u00f3n relacionada con nuestro estudio, incluso los detalles de nuestro protocolo de estudio\".\n\"Seguimos totalmente enfocados en desarrollar una vacuna contra la COVID-19 segura, eficaz y tan necesaria para las personas de todo el mundo\", afirm\u00f3 Paul Stoffels, M.D., vicepresidente del Comit\u00e9 ejecutivo y director cient\u00edfico, Johnson & Johnson. \"Valoramos much\u00edsimo la colaboraci\u00f3n y el apoyo de nuestros socios cient\u00edficos y de las autoridades sanitarias mundiales, mientras nuestro equipo global de expertos trabaja incansablemente en el desarrollo de la vacuna y ampl\u00eda nuestra capacidad de producci\u00f3n con el objetivo de suministrar una vacuna con autorizaci\u00f3n para uso de emergencia a principios de 2021\".\nLa candidata a la vacuna contra la COVID-19 de Janseen aprovecha la plataforma tecnol\u00f3gica\n[AdVac\u00ae de la Empresa](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=1961049325&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1181941441%26u%3Dhttps%253A%252F%252Fwww.janssen.com%252Finfectious-diseases-and-vaccines%252Fpatented-technologies%26a%3DAdVac%25C2%25AE%2Btechnology&a=AdVac%C2%AE+de+la+Empresa), que tambi\u00e9n se utiliz\u00f3 para desarrollar y producir la vacuna del \u00e9bola de Janseen aprobada por la Comisi\u00f3n Europea y crear sus candidatas a la vacuna del zika, el virus cincitial respiratorio y el VIH. La plataforma tecnol\u00f3gica AdVac\u00ae de Janseen se ha utilizado para vacunar a m\u00e1s de 100.000 personas hasta la fecha a trav\u00e9s de los programas de vacunas en etapa de investigaci\u00f3n de Janssen.\nEn caso de prosperar, se estima que la vacuna permanecer\u00e1 estable durante dos a\u00f1os a -20 \u00b0C y al menos tres meses a 2-8 \u00b0C mediante la tecnolog\u00eda AdVac\u00ae de Janseen. Esto permite que la candidata a la vacuna sea compatible con los canales de distribuci\u00f3n est\u00e1ndar de vacunas, por lo que no se necesitar\u00eda una nueva infraestructura para que llegue a las personas que la necesiten.\nESTUDIO ENSEMBLE DE FASE 3\nEl estudio ENSEMBLE de fase 3 es un ensayo cl\u00ednico aleatorizado, doble ciego y controlado con placebo que est\u00e1 dise\u00f1ado para evaluar la seguridad y eficacia de una sola dosis de la vacuna frente al placebo en un m\u00e1ximo de 60.000 adultos, de 18 a\u00f1os y m\u00e1s, que incluye una representaci\u00f3n importante que aquellos mayores de 60 a\u00f1os. El ensayo incluir\u00e1 a voluntarios con y sin comorbilidades asociadas con un mayor riesgo de desarrollar COVID-19 grave, y reclutar\u00e1 a participantes en Argentina, Brasil, Chile, Colombia, M\u00e9xico, Per\u00fa, Sud\u00e1frica y Estados Unidos. Para evaluar la eficacia de la vacuna contra la COVID-19 de Janssen, se activar\u00e1n pa\u00edses y centros para ensayos cl\u00ednicos que presenten una alta incidencia de la COVID-19 y la capacidad de lograr un r\u00e1pido inicio.\nBasada en un legado de acciones impulsadas por objetivos y un compromiso con la diversidad y la inclusi\u00f3n, la Empresa tiene como fin lograr la representaci\u00f3n de poblaciones que han sido afectadas por la pandemia de manera desproporcionada en la implementaci\u00f3n de su programa de ensayos de fase 3 de la vacuna contra la COVID-19. En EE. UU., esto incluye una representaci\u00f3n importante de participantes negros, hispanos o latinos, americanos nativos y nativos de Alaska.\nENSEMBLE se inicia en colaboraci\u00f3n con la Autoridad para la Investigaci\u00f3n y Desarrollo Biom\u00e9dico Avanzado (BARDA), parte de la Oficina del Subsecretario de Preparaci\u00f3n y Respuesta del Departamento de Salud y Servicios Humanos (HHS) de EE. UU. conforme al Acuerdo de Otras Transacciones HHSO100201700018C, y el Instituto Nacional de Alergias y Enfermedades Infecciosas (NIAID), parte de los Institutos Nacionales de Salud (NIH) del HHS.\nParalelamente, la Empresa en principio tambi\u00e9n ha aceptado\n[colaborar](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=1577797497&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D125471153%26u%3Dhttps%253A%252F%252Fwww.jnj.com%252Four-company%252Fjohnson-johnson-announces-collaboration-in-principle-with-the-united-kingdom-on-additional-phase-3-study-and-agreement-to-supply-its-covid-19-vaccine-candidate%26a%3Dcollaborate&a=colaborar) con el Reino Unido de Gran Breta\u00f1a e Irlanda del Norte (el Gobierno del Reino Unido) en otro ensayo cl\u00ednico de fase 3 en varios pa\u00edses para explorar el r\u00e9gimen de dos dosis de la candidata a la vacuna de Janssen.\n\"Con nuestra candidata a la vacuna que ahora se encuentra en nuestro ensayo de fase 3 global, estamos m\u00e1s cerca de encontrar una soluci\u00f3n para la COVID-19. Para seleccionar esta candidata a la vacuna, utilizamos un enfoque de alto nivel cient\u00edfico y basado en evidencia. Estamos muy agradecidos por los incansables esfuerzos de nuestros investigadores y por la colaboraci\u00f3n fundamental de los participantes que se ofrecieron como voluntarios para formar parte de nuestros estudios. Trabajamos juntos para ayudar a combatir esta pandemia\", expres\u00f3 Mathai Mammen, M.D., Ph.D., director global, Investigaci\u00f3n y Desarrollo de Janssen, LLC, Johnson & Johnson.\nLa Empresa conversa de manera constante con muchas partes interesadas, incluso con gobiernos nacionales y organizaciones globales, en el marco de sus esfuerzos por cumplir su compromiso de lograr que la candidata a la vacuna sea accesible a nivel mundial, siempre y cuando demuestre ser segura, eficaz y obtenga la autorizaci\u00f3n reglamentaria.\nPara obtener m\u00e1s informaci\u00f3n sobre el enfoque multidimensional de Johnson & Johnson para ayudar a combatir la pandemia, visite:\n[www.jnj.com/coronavirus](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=2174915427&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D972281942%26u%3Dhttp%253A%252F%252Fwww.jnj.com%252Fcoronavirus%26a%3Dwww.jnj.com%252Fcoronavirus&a=www.jnj.com%2Fcoronavirus).\nAcerca de Johnson & Johnson\nEn Johnson & Johnson, creemos que la buena salud es la base para tener vidas llenas de energ\u00eda, comunidades pr\u00f3speras y progreso. Es por eso que llevamos m\u00e1s de 130 a\u00f1os centrados en mejorar el bienestar de las personas de todas las edades en todas las etapas de la vida. Hoy, como la empresa m\u00e1s grande y con m\u00e1s presencia internacional de cuidado de la salud del mundo, asumimos el compromiso de utilizar nuestra magnitud y nuestro alcance para el bien com\u00fan. Nos esforzamos por mejorar el acceso y la asequibilidad, crear comunidades m\u00e1s saludables y poner condiciones f\u00edsicas, mentales y ambientales sanas al alcance de todas las personas en cualquier parte. Buscamos combinar nuestro coraz\u00f3n, nuestra capacidad cient\u00edfica y nuestro ingenio para generar un cambio profundo en la trayectoria de la salud para la humanidad. Obtenga m\u00e1s informaci\u00f3n en\n[www.jnj.com](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=3848262118&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1797651163%26u%3Dhttp%253A%252F%252Fwww.jnj.com%252F%26a%3Dwww.jnj.com&a=www.jnj.com). S\u00edganos en [@JNJNews](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=4155470862&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D3430601698%26u%3Dhttp%253A%252F%252Fwww.twitter.com%252Fjnjnews%26a%3D%2540JNJNews&a=%40JNJNews).\nAcerca de Janssen Pharmaceutical Companies\nEn Janssen, estamos creando un futuro donde la enfermedad sea algo del pasado. Somos las empresas farmac\u00e9uticas de Johnson & Johnson (Pharmaceutical Companies of Johnson & Johnson) y trabajamos sin descanso para que dicho futuro se convierta en una realidad para los pacientes de todo el mundo combatiendo la enfermedad con ciencia, mejorando el acceso con inventiva y curando la desesperanza con el coraz\u00f3n. Nos centramos en las \u00e1reas de la medicina en las que podemos causar mayor impacto: el sistema cardiovascular y el metabolismo, la inmunolog\u00eda, las enfermedades infecciosas y las vacunas, la neurociencia, la oncolog\u00eda y la hipertensi\u00f3n pulmonar. Obtenga m\u00e1s informaci\u00f3n en\n[www.janssen.com](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=3845457817&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D3956113430%26u%3Dhttp%253A%252F%252Fwww.janssen.com%252F%26a%3Dwww.janssen.com&a=www.janssen.com). S\u00edganos en [@JanssenGlobal](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=930301523&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1289483207%26u%3Dhttps%253A%252F%252Ftwitter.com%252FJanssenGlobal%26a%3D%2540JanssenGlobal&a=%40JanssenGlobal).\nAviso a los inversionistas sobre las declaraciones a futuro\nEste comunicado de prensa contiene \"declaraciones a futuro\" seg\u00fan se define en la Ley de Reforma sobre Litigios de Valores Privados (The Private Securities Litigation Reform Act) de 1995 sobre el desarrollo de una posible vacuna preventiva para la COVID-19. Se recomienda al lector que no conf\u00ede en estas declaraciones a futuro. Estas se basan en expectativas actuales de eventos futuros. Si las suposiciones subyacentes resultan imprecisas o si se materializan riesgos o incertidumbres conocidos o desconocidos, los resultados reales pueden variar significativamente respecto de las expectativas y proyecciones de Janssen Pharmaceutical Companies o de Johnson & Johnson. Entre los riesgos e incertidumbres se incluyen, entre otros, dificultades e incertidumbres inherentes a la investigaci\u00f3n y el desarrollo de productos, incluida la incertidumbre sobre el \u00e9xito cl\u00ednico y la obtenci\u00f3n de aprobaciones normativas; incertidumbre sobre el \u00e9xito comercial; dificultades y retrasos en la producci\u00f3n; la competencia, incluidos los avances tecnol\u00f3gicos, nuevos productos y patentes que obtenga la competencia; impugnaciones de patentes; inquietudes sobre la eficacia o la seguridad del producto que provoquen su retirada del mercado o acciones normativas; cambios en el comportamiento y los patrones de gasto de los compradores de productos y servicios sanitarios; cambios en las leyes y normativas aplicables, incluidas reformas sanitarias a nivel global, y tendencias hacia la contenci\u00f3n del gasto sanitario. Se puede encontrar una lista adicional y descripciones de estos riesgos, incertidumbres y otros factores en el Informe Anual de Johnson & Johnson en el formulario 10-K del a\u00f1o fiscal finalizado el 29 de diciembre de 2019, entre ellas, en las secciones \"Cautionary Note Regarding Forward-Looking Statements\" (Advertencia cautelar sobre declaraciones prospectivas) y \"Item 1A. Risk Factors\" (Art\u00edculo 1A. Factores de riesgo), y en el informe trimestral m\u00e1s reciente de la compa\u00f1\u00eda, presentado en el formulario 10-Q, y en otras presentaciones de la empresa ante la Securities and Exchange Commission (Comisi\u00f3n de Valores). Se pueden obtener copias de estas presentaciones en l\u00ednea en\n[www.sec.gov](http://www.sec.gov), [www.jnj.com](http://www.jnj.com) o solicitarlas a Johnson & Johnson. Ninguna de las empresas que forman parte de Janssen Pharmaceutical Companies o Johnson & Johnson se compromete a actualizar ninguna de las declaraciones a futuro como resultado de nueva informaci\u00f3n o de futuros acontecimientos o desarrollos.\nLogo:\n[https://mma.prnewswire.com/media/403394/Johnson_and_Johnson_Logo.jpg](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=175754704&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D650214627%26u%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F403394%252FJohnson_and_Johnson_Logo.jpg%26a%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F403394%252FJohnson_and_Johnson_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F403394%2FJohnson_and_Johnson_Logo.jpg)\nFUENTE Johnson & Johnson\nRelated Links\nSOURCE Johnson & Johnson", "language": null, "image": "https://mma.prnewswire.com/media/403394/Johnson_and_Johnson_Logo.jpg?p=facebook", "pagetype": "articles", "links": ["/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "https://portal.prnewswire.com/Login.aspx", "https://www.prnewswire.com/account/online-membership-form/", "https://gdpr.cision.com/", "https://portal.prnewswire.com/Login.aspx", "/", "/news-releases/", "/products/overview/", "/contact-us/", "#", "/news-releases/", "/news-releases/news-releases-list/", "/news-releases/all-public-company-news/", "/news-releases/english-releases/", "/news-releases/", "/news-releases/multimedia/", "/news-releases/multimedia/multimedia-list/", "/news-releases/photos/photos-list/", "/news-releases/videos/videos-list/", "/news-releases/multimedia/", "/news-releases/latest-news-topics/", "/news-releases/latest-news-topics/", "#", "/news-releases/automotive-transportation-latest-news/", "/news-releases/automotive-transportation-latest-news/automotive-transportation-latest-news-list/", "/news-releases/automotive-transportation-latest-news/aerospace-defense-list/", "/news-releases/automotive-transportation-latest-news/air-freight-list/", "/news-releases/automotive-transportation-latest-news/airlines-aviation-list/", "/news-releases/automotive-transportation-latest-news/automotive-list/", "/news-releases/automotive-transportation-latest-news/maritime-shipbuilding-list/", "/news-releases/automotive-transportation-latest-news/railroads-and-intermodal-transportation-list/", "/news-releases/automotive-transportation-latest-news/supply-chain-logistics-list/", "/news-releases/automotive-transportation-latest-news/transportation-trucking-railroad-list/", "/news-releases/automotive-transportation-latest-news/travel-list/", "/news-releases/automotive-transportation-latest-news/trucking-and-road-transportation-list/", "/news-releases/automotive-transportation-latest-news/", "/news-releases/automotive-transportation-latest-news/automotive-transportation-latest-news-list/", "/news-releases/business-technology-latest-news/", "/news-releases/business-technology-latest-news/business-technology-latest-news-list/", "/news-releases/business-technology-latest-news/blockchain-list/", "/news-releases/business-technology-latest-news/broadcast-tech-list/", "/news-releases/business-technology-latest-news/computer-electronics-list/", "/news-releases/business-technology-latest-news/computer-hardware-list/", "/news-releases/business-technology-latest-news/computer-software-list/", "/news-releases/business-technology-latest-news/data-analytics-list/", "/news-releases/business-technology-latest-news/electronic-commerce-list/", "/news-releases/business-technology-latest-news/electronic-components-list/", "/news-releases/business-technology-latest-news/electronic-design-automation-list/", "/news-releases/business-technology-latest-news/financial-technology-list/", "/news-releases/business-technology-latest-news/high-tech-security-list/", "/news-releases/business-technology-latest-news/internet-technology-list/", "/news-releases/business-technology-latest-news/nanotechnology-list/", "/news-releases/business-technology-latest-news/networks-list/", "/news-releases/business-technology-latest-news/peripherals-list/", "/news-releases/business-technology-latest-news/semiconductors-list/", "/news-releases/business-technology-latest-news/", "/news-releases/business-technology-latest-news/business-technology-latest-news-list/", "/news-releases/entertainment-media-latest-news/", "/news-releases/entertainment-media-latest-news/entertainment-media-latest-news-list/", "/news-releases/entertainment-media-latest-news/advertising-list/", "/news-releases/entertainment-media-latest-news/art-list/", "/news-releases/entertainment-media-latest-news/books-list/", "/news-releases/entertainment-media-latest-news/entertainment-list/", "/news-releases/entertainment-media-latest-news/film-and-motion-picture-list/", "/news-releases/entertainment-media-latest-news/magazines-list/", "/news-releases/entertainment-media-latest-news/music-list/", "/news-releases/entertainment-media-latest-news/publishing-information-services-list/", "/news-releases/entertainment-media-latest-news/radio-list/", "/news-releases/entertainment-media-latest-news/television-list/", "/news-releases/entertainment-media-latest-news/", "/news-releases/entertainment-media-latest-news/entertainment-media-latest-news-list/", "/news-releases/financial-services-latest-news/", "/news-releases/financial-services-latest-news/financial-services-latest-news-list/", "/news-releases/financial-services-latest-news/accounting-news-issues-list/", "/news-releases/financial-services-latest-news/acquisitions-mergers-and-takeovers-list/", "/news-releases/financial-services-latest-news/banking-financial-services-list/", "/news-releases/financial-services-latest-news/bankruptcy-list/", "/news-releases/financial-services-latest-news/bond-stock-ratings-list/", "/news-releases/financial-services-latest-news/conference-call-announcements-list/", "/news-releases/financial-services-latest-news/contracts-list/", "/news-releases/financial-services-latest-news/cryptocurrency-list/", "/news-releases/financial-services-latest-news/dividends-list/", "/news-releases/financial-services-latest-news/earnings-list/", "/news-releases/financial-services-latest-news/earnings-forecasts-projections-list/", "/news-releases/financial-services-latest-news/financing-agreements-list/", "/news-releases/financial-services-latest-news/insurance-list/", "/news-releases/financial-services-latest-news/investment-opinions-list/", "/news-releases/financial-services-latest-news/joint-ventures-list/", "/news-releases/financial-services-latest-news/mutual-funds-list/", "/news-releases/financial-services-latest-news/private-placement-list/", "/news-releases/financial-services-latest-news/real-estate-list/", "/news-releases/financial-services-latest-news/restructuring-recapitalization-list/", "/news-releases/financial-services-latest-news/sales-reports-list/", "/news-releases/financial-services-latest-news/shareholder-activism-list/", "/news-releases/financial-services-latest-news/shareholder-meetings-list/", "/news-releases/financial-services-latest-news/stock-offering-list/", "/news-releases/financial-services-latest-news/stock-split-list/", "/news-releases/financial-services-latest-news/venture-capital-list/", "/news-releases/financial-services-latest-news/", "/news-releases/financial-services-latest-news/financial-services-latest-news-list/", "/news-releases/general-business-latest-news/", "/news-releases/general-business-latest-news/general-business-latest-news-list/", "/news-releases/general-business-latest-news/awards-list/", "/news-releases/general-business-latest-news/commercial-real-estate-list/", "/news-releases/general-business-latest-news/corporate-expansion-list/", "/news-releases/general-business-latest-news/earnings-list/", "/news-releases/general-business-latest-news/environmental-social-governance-list/", "/news-releases/general-business-latest-news/human-resource-workforce-management-list/", "/news-releases/general-business-latest-news/licensing-list/", "/news-releases/general-business-latest-news/new-products-services-list/", "/news-releases/general-business-latest-news/obituaries-list/", "/news-releases/general-business-latest-news/outsourcing-businesses-list/", "/news-releases/general-business-latest-news/overseas-real-estate-list/", "/news-releases/general-business-latest-news/personnel-announcements-list/", "/news-releases/general-business-latest-news/real-estate-transactions-list/", "/news-releases/general-business-latest-news/residential-real-estate-list/", "/news-releases/general-business-latest-news/small-business-services-list/", "/news-releases/general-business-latest-news/socially-responsible-investing-list/", "/news-releases/general-business-latest-news/surveys-polls-and-research-list/", "/news-releases/general-business-latest-news/trade-show-news-list/", "/news-releases/general-business-latest-news/", "/news-releases/general-business-latest-news/general-business-latest-news-list/", "#", "/news-releases/consumer-technology-latest-news/", "/news-releases/consumer-technology-latest-news/consumer-technology-latest-news-list/", "/news-releases/consumer-technology-latest-news/artificial-intelligence-list/", "/news-releases/consumer-technology-latest-news/blockchain-list/", "/news-releases/consumer-technology-latest-news/cloud-computing-internet-of-things-list/", "/news-releases/consumer-technology-latest-news/computer-electronics-list/", "/news-releases/consumer-technology-latest-news/computer-hardware-list/", "/news-releases/consumer-technology-latest-news/computer-software-list/", "/news-releases/consumer-technology-latest-news/consumer-electronics-list/", "/news-releases/consumer-technology-latest-news/cryptocurrency-list/", "/news-releases/consumer-technology-latest-news/data-analytics-list/", "/news-releases/consumer-technology-latest-news/electronic-commerce-list/", "/news-releases/consumer-technology-latest-news/electronic-gaming-list/", "/news-releases/consumer-technology-latest-news/financial-technology-list/", "/news-releases/consumer-technology-latest-news/mobile-entertainment-list/", "/news-releases/consumer-technology-latest-news/multimedia-internet-list/", "/news-releases/consumer-technology-latest-news/peripherals-list/", "/news-releases/consumer-technology-latest-news/social-media-list/", "/news-releases/consumer-technology-latest-news/science-tech-engineering-math-list/", "/news-releases/consumer-technology-latest-news/supply-chain-logistics-list/", "/news-releases/consumer-technology-latest-news/wireless-communications-list/", "/news-releases/consumer-technology-latest-news/", "/news-releases/consumer-technology-latest-news/consumer-technology-latest-news-list/", "/news-releases/energy-latest-news/", "/news-releases/energy-latest-news/energy-latest-news-list/", "/news-releases/energy-latest-news/alternative-energies-list/", "/news-releases/energy-latest-news/chemical-list/", "/news-releases/energy-latest-news/electrical-utilities-list/", "/news-releases/energy-latest-news/gas-list/", "/news-releases/energy-latest-news/general-manufacturing-list/", "/news-releases/energy-latest-news/mining-list/", "/news-releases/energy-latest-news/mining-metals-list/", "/news-releases/energy-latest-news/oil-energy-list/", "/news-releases/energy-latest-news/oil-and-gas-discoveries-list/", "/news-releases/energy-latest-news/utilities-list/", "/news-releases/energy-latest-news/water-utilities-list/", "/news-releases/energy-latest-news/", "/news-releases/energy-latest-news/energy-latest-news-list/", "/news-releases/environment-latest-news/", "/news-releases/environment-latest-news/environment-latest-news-list/", "/news-releases/environment-latest-news/conservation-recycling-list/", "/news-releases/environment-latest-news/environmental-issues-list/", "/news-releases/environment-latest-news/environmental-policy-list/", "/news-releases/environment-latest-news/environmental-products-services-list/", "/news-releases/environment-latest-news/green-technology-list/", "/news-releases/environment-latest-news/natural-disasters/", "/news-releases/environment-latest-news/", "/news-releases/environment-latest-news/environment-latest-news-list/", "/news-releases/heavy-industry-manufacturing-latest-news/", "/news-releases/heavy-industry-manufacturing-latest-news/heavy-industry-manufacturing-latest-news-list/", "/news-releases/heavy-industry-manufacturing-latest-news/aerospace-defense-list/", "/news-releases/heavy-industry-manufacturing-latest-news/agriculture-list/", "/news-releases/heavy-industry-manufacturing-latest-news/chemical-list/", "/news-releases/heavy-industry-manufacturing-latest-news/construction-building-list/", "/news-releases/heavy-industry-manufacturing-latest-news/general-manufacturing-list/", "/news-releases/heavy-industry-manufacturing-latest-news/hvac-list/", "/news-releases/heavy-industry-manufacturing-latest-news/machinery-list/", "/news-releases/heavy-industry-manufacturing-latest-news/machine-tools-metalworking-and-metallury-list/", "/news-releases/heavy-industry-manufacturing-latest-news/mining-list/", "/news-releases/heavy-industry-manufacturing-latest-news/mining-metals-list/", "/news-releases/heavy-industry-manufacturing-latest-news/paper-forest-products-containers-list/", "/news-releases/heavy-industry-manufacturing-latest-news/precious-metals-list/", "/news-releases/heavy-industry-manufacturing-latest-news/textiles-list/", "/news-releases/heavy-industry-manufacturing-latest-news/tobacco-list/", "/news-releases/heavy-industry-manufacturing-latest-news/", "/news-releases/heavy-industry-manufacturing-latest-news/heavy-industry-manufacturing-latest-news-list/", "/news-releases/telecommunications-latest-news/", "/news-releases/telecommunications-latest-news/telecommunications-latest-news-list/", "/news-releases/telecommunications-latest-news/carriers-and-services-list/", "/news-releases/telecommunications-latest-news/mobile-entertainment-list/", "/news-releases/telecommunications-latest-news/networks-list/", "/news-releases/telecommunications-latest-news/peripherals-list/", "/news-releases/telecommunications-latest-news/telecommunications-equipment-list/", "/news-releases/telecommunications-latest-news/telecommunications-industry-list/", "/news-releases/telecommunications-latest-news/voip-list/", "/news-releases/telecommunications-latest-news/wireless-communications-list/", "/news-releases/telecommunications-latest-news/", "/news-releases/telecommunications-latest-news/telecommunications-latest-news-list/", "#", "/news-releases/consumer-products-retail-latest-news/", "/news-releases/consumer-products-retail-latest-news/consumer-products-retail-latest-news-list/", "/news-releases/consumer-products-retail-latest-news/animals-pets-list/", "/news-releases/consumer-products-retail-latest-news/beers-wines-and-spirits-list/", "/news-releases/consumer-products-retail-latest-news/beverages-list/", "/news-releases/consumer-products-retail-latest-news/bridal-services-list/", "/news-releases/consumer-products-retail-latest-news/cannabis-list/", "/news-releases/consumer-products-retail-latest-news/cosmetics-and-personal-care-list/", "/news-releases/consumer-products-retail-latest-news/fashion-list/", "/news-releases/consumer-products-retail-latest-news/food-beverages-list/", "/news-releases/consumer-products-retail-latest-news/furniture-and-furnishings-list/", "/news-releases/consumer-products-retail-latest-news/home-improvements-list/", "/news-releases/consumer-products-retail-latest-news/household-consumer-cosmetics-list/", "/news-releases/consumer-products-retail-latest-news/household-products-list/", "/news-releases/consumer-products-retail-latest-news/jewelry-list/", "/news-releases/consumer-products-retail-latest-news/non-alcoholic-beverages-list/", "/news-releases/consumer-products-retail-latest-news/office-products-list/", "/news-releases/consumer-products-retail-latest-news/organic-food-list/", "/news-releases/consumer-products-retail-latest-news/product-recalls-list/", "/news-releases/consumer-products-retail-latest-news/restaurants-list/", "/news-releases/consumer-products-retail-latest-news/retail-list/", "/news-releases/consumer-products-retail-latest-news/supermarkets-list/", "/news-releases/consumer-products-retail-latest-news/toys-list/", "/news-releases/consumer-products-retail-latest-news/", "/news-releases/consumer-products-retail-latest-news/consumer-products-retail-latest-news-list/", "/news-releases/entertainment-media-latest-news/", "/news-releases/entertainment-media-latest-news/entertainment-media-latest-news-list/", "/news-releases/entertainment-media-latest-news/advertising-list/", "/news-releases/entertainment-media-latest-news/art-list/", "/news-releases/entertainment-media-latest-news/books-list/", "/news-releases/entertainment-media-latest-news/entertainment-list/", "/news-releases/entertainment-media-latest-news/film-and-motion-picture-list/", "/news-releases/entertainment-media-latest-news/magazines-list/", "/news-releases/entertainment-media-latest-news/music-list/", "/news-releases/entertainment-media-latest-news/publishing-information-services-list/", "/news-releases/entertainment-media-latest-news/radio-list/", "/news-releases/entertainment-media-latest-news/television-list/", "/news-releases/entertainment-media-latest-news/", "/news-releases/entertainment-media-latest-news/entertainment-media-latest-news-list/", "/news-releases/health-latest-news/", "/news-releases/health-latest-news/health-latest-news-list/", "/news-releases/health-latest-news/biometrics-list/", "/news-releases/health-latest-news/biotechnology-list/", "/news-releases/health-latest-news/clinical-trials-medical-discoveries-list/", "/news-releases/health-latest-news/dentistry-list/", "/news-releases/health-latest-news/fda-approval-list/", "/news-releases/health-latest-news/fitness-wellness-list/", "/news-releases/health-latest-news/health-care-hospitals-list/", "/news-releases/health-latest-news/health-insurance-list/", "/news-releases/health-latest-news/infection-control-list/", "/news-releases/health-latest-news/international-medical-approval-list/", "/news-releases/health-latest-news/medical-equipment-list/", "/news-releases/health-latest-news/medical-pharmaceuticals-list/", "/news-releases/health-latest-news/mental-health-list/", "/news-releases/health-latest-news/pharmaceuticals-list/", "/news-releases/health-latest-news/supplementary-medicine-list/", "/news-releases/health-latest-news/", "/news-releases/health-latest-news/health-latest-news-list/", "/news-releases/sports-latest-news/", "/news-releases/sports-latest-news/sports-latest-news-list/", "/news-releases/sports-latest-news/general-sports-list/", "/news-releases/sports-latest-news/outdoors-camping-hiking-list/", "/news-releases/sports-latest-news/sporting-events-list/", "/news-releases/sports-latest-news/sports-equipment-accessories-list/", "/news-releases/sports-latest-news/", "/news-releases/sports-latest-news/sports-latest-news-list/", "/news-releases/travel-latest-news/", "/news-releases/travel-latest-news/travel-latest-news-list/", "/news-releases/travel-latest-news/amusement-parks-and-tourist-attractions-list/", "/news-releases/travel-latest-news/gambling-casinos-list/", "/news-releases/travel-latest-news/hotels-and-resorts-list/", "/news-releases/travel-latest-news/leisure-tourism-list/", "/news-releases/travel-latest-news/outdoors-camping-hiking-list/", "/news-releases/travel-latest-news/passenger-aviation-list/", "/news-releases/travel-latest-news/travel-industry-list/", "/news-releases/travel-latest-news/", "/news-releases/travel-latest-news/travel-latest-news-list/", "#", "/news-releases/policy-public-interest-latest-news/", "/news-releases/policy-public-interest-latest-news/policy-public-interest-latest-news-list/", "/news-releases/policy-public-interest-latest-news/advocacy-group-opinion-list/", "/news-releases/policy-public-interest-latest-news/animal-welfare-list/", "/news-releases/policy-public-interest-latest-news/congressional-presidential-campaigns-list/", "/news-releases/policy-public-interest-latest-news/corporate-social-responsibility-list/", "/news-releases/policy-public-interest-latest-news/domestic-policy-list/", "/news-releases/policy-public-interest-latest-news/economic-news-trends-analysis-list/", "/news-releases/policy-public-interest-latest-news/education-list/", "/news-releases/policy-public-interest-latest-news/environmental-list/", "/news-releases/policy-public-interest-latest-news/european-government-list/", "/news-releases/policy-public-interest-latest-news/fda-approval-list/", "/news-releases/policy-public-interest-latest-news/federal-and-state-legislation-list/", "/news-releases/policy-public-interest-latest-news/federal-executive-branch-agency-news-list/", "/news-releases/policy-public-interest-latest-news/foreign-policy-international-affairs-list/", "/news-releases/policy-public-interest-latest-news/homeland-security-list/", "/news-releases/policy-public-interest-latest-news/labor-union-news-list/", "/news-releases/policy-public-interest-latest-news/legal-issues-list/", "/news-releases/policy-public-interest-latest-news/natural-disasters-list/", "/news-releases/policy-public-interest-latest-news/not-for-profit-list/", "/news-releases/policy-public-interest-latest-news/patent-law-list/", "/news-releases/policy-public-interest-latest-news/public-safety-list/", "/news-releases/policy-public-interest-latest-news/trade-policy-list/", "/news-releases/policy-public-interest-latest-news/us-state-policy-news-list/", "/news-releases/policy-public-interest-latest-news/", "/news-releases/policy-public-interest-latest-news/policy-public-interest-latest-news-list/", "#", "/news-releases/multicultural-latest-news/", "/news-releases/multicultural-latest-news/multicultural-latest-news-list/", "/news-releases/multicultural-latest-news/native-american-list/", "/news-releases/multicultural-latest-news/african-american-related-news-list/", "/news-releases/multicultural-latest-news/asian-related-news-list/", "/news-releases/multicultural-latest-news/children-related-news-list/", "/news-releases/multicultural-latest-news/diversity-equity-inclusion/", "/news-releases/multicultural-latest-news/hispanic-oriented-news-list/", "/news-releases/multicultural-latest-news/lesbian-gay-bisexual-list/", "/news-releases/multicultural-latest-news/mens-interest-list/", "/news-releases/multicultural-latest-news/people-with-disabilities-list/", "/news-releases/multicultural-latest-news/religion-list/", "/news-releases/multicultural-latest-news/senior-citizens-list/", "/news-releases/multicultural-latest-news/veterans-list/", "/news-releases/multicultural-latest-news/women-related-news-list/", "/news-releases/multicultural-latest-news/", "/news-releases/multicultural-latest-news/multicultural-latest-news-list/", "/ae/ar/news-releases/", "/comunicados-de-prensa/", "/comunicados-para-a-imprensa/", "/cs/tiskova-zprava/", "/da/pressemeddelelser/", "/de/pressemitteilungen/", "/es/comunicados-de-prensa/", "/fr/communiques-de-presse/", "/it/comunicati-stampa/", "/nl/persberichten/", "/no/pressemeldinger/", "/pl/komunikat-prasowy/", "/pt/comunicados-de-imprensa/", "/ru/press-releases/", "/sk/tlacova-sprava/", "/fi/lehdistotiedotteet/", "/sv/pressmeddelanden/", "/products/overview/", "/products/content-distribution/", "/products/communications-cloud/", "/products/ir-compliance/", "/guaranteed-paid-placement/", "/products/all-products/", "/contact-us/general-inquiries/", "/request-a-demo/", "/contact-us/editorial-bureaus/", "/contact-us/partnerships/", "/contact-us/media-inquiries/", "/contact-us/worldwide-offices/", "#nav-mobile", "/", "https://portal.prnewswire.com", "/contact-us/", "javascript:void(0)", "/contact-us/", "/contact-us/", "tel:+1-888-776-0942", "javascript:void(0)", "#", "https://portal.prnewswire.com/", "https://www.prnewswire.com/account/online-membership-form/", "https://portal.prnewswire.com/", "/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "/rss/", "https://gdpr.cision.com", "https://twitter.com/PRNewswire", "https://www.facebook.com/pages/PR-Newswire/26247320522", "https://www.linkedin.com/company/pr-newswire/", "/news-releases/", "/news-releases/multimedia/", "/news-releases/latest-news-topics/", "/news-releases/automotive-transportation-latest-news/", "/news-releases/business-technology-latest-news/", "/news-releases/entertainment-media-latest-news/", "/news-releases/financial-services-latest-news/", "/news-releases/general-business-latest-news/", "/news-releases/consumer-technology-latest-news/", "/news-releases/energy-latest-news/", "/news-releases/environment-latest-news/", "/news-releases/heavy-industry-manufacturing-latest-news/", "/news-releases/telecommunications-latest-news/", "/news-releases/consumer-products-retail-latest-news/", "/news-releases/entertainment-media-latest-news/", "/news-releases/health-latest-news/", "/news-releases/sports-latest-news/", "/news-releases/travel-latest-news/", "/news-releases/multicultural-latest-news/", "https://portal.prnewswire.com/", "https://www.prnewswire.com/account/online-membership-form/", "https://portal.prnewswire.com/", "/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "/rss/", "https://gdpr.cision.com", "https://twitter.com/PRNewswire", "https://www.facebook.com/pages/PR-Newswire/26247320522", "https://www.linkedin.com/company/pr-newswire/", "/products/overview/", "/products/content-distribution/", "/products/communications-cloud/", "/products/ir-compliance/", "/products/all-products/", "https://portal.prnewswire.com/", "https://www.prnewswire.com/account/online-membership-form/", "https://portal.prnewswire.com/", "/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "/rss/", "https://gdpr.cision.com", "https://twitter.com/PRNewswire", "https://www.facebook.com/pages/PR-Newswire/26247320522", "https://www.linkedin.com/company/pr-newswire/", "/contact-us/#general", "/request-a-demo/", "/contact-us/#editorial", "/contact-us/#partnerships", "/contact-us/#media", "/contact-us/#worldwide", "https://portal.prnewswire.com/", "https://www.prnewswire.com/account/online-membership-form/", "https://portal.prnewswire.com/", "/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "/rss/", "https://gdpr.cision.com", "https://twitter.com/PRNewswire", "https://www.facebook.com/pages/PR-Newswire/26247320522", "https://www.linkedin.com/company/pr-newswire/", "/news-releases/johnson--johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssens-covid-19-vaccine-candidate-301136522.html", "/in/news-releases/johnson-amp-johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssen-s-covid-19-vaccine-candidate-877450595.html", "/news-releases/johnson-amp-johnson-inicia-el-ensayo-clinico-en-fase-3-del-candidato-de-vacuna-para-la-covid-19-de-janssen-854359037.html", "#", "/news/johnson-%26-johnson/", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", null, "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "#financial-modal", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=1139456354&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1522581176%26u%3Dhttps%253A%252F%252Fwww.jnj.com%252Fcoronavirus%252Fcovid-19-phase-3-study-clinical-protocol%26a%3Dstudy%2Bprotocol&a=protocolo+de+estudio", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=1961049325&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1181941441%26u%3Dhttps%253A%252F%252Fwww.janssen.com%252Finfectious-diseases-and-vaccines%252Fpatented-technologies%26a%3DAdVac%25C2%25AE%2Btechnology&a=AdVac%C2%AE+de+la+Empresa", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=1577797497&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D125471153%26u%3Dhttps%253A%252F%252Fwww.jnj.com%252Four-company%252Fjohnson-johnson-announces-collaboration-in-principle-with-the-united-kingdom-on-additional-phase-3-study-and-agreement-to-supply-its-covid-19-vaccine-candidate%26a%3Dcollaborate&a=colaborar", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=2174915427&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D972281942%26u%3Dhttp%253A%252F%252Fwww.jnj.com%252Fcoronavirus%26a%3Dwww.jnj.com%252Fcoronavirus&a=www.jnj.com%2Fcoronavirus", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=3848262118&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1797651163%26u%3Dhttp%253A%252F%252Fwww.jnj.com%252F%26a%3Dwww.jnj.com&a=www.jnj.com", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=4155470862&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D3430601698%26u%3Dhttp%253A%252F%252Fwww.twitter.com%252Fjnjnews%26a%3D%2540JNJNews&a=%40JNJNews", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=3845457817&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D3956113430%26u%3Dhttp%253A%252F%252Fwww.janssen.com%252F%26a%3Dwww.janssen.com&a=www.janssen.com", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=930301523&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1289483207%26u%3Dhttps%253A%252F%252Ftwitter.com%252FJanssenGlobal%26a%3D%2540JanssenGlobal&a=%40JanssenGlobal", "http://www.sec.gov", "http://www.jnj.com", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=175754704&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D650214627%26u%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F403394%252FJohnson_and_Johnson_Logo.jpg%26a%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F403394%252FJohnson_and_Johnson_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F403394%2FJohnson_and_Johnson_Logo.jpg", "http://www.jnj.com", "https://gdpr.cision.com/PRN-Consumer-Newsletter", "https://gdpr.cision.com/PRN-Consumer-Newsletter", "https://gdpr.cision.com/PRN-Consumer-Newsletter", "https://gdpr.cision.com/PRN-Consumer-Newsletter", "tel:Cision%20Distribution%20888-776-0942", "javascript://Chat", "/contact-us/general-inquiries/", "/request-a-demo/", "/contact-us/editorial-bureaus/", "/contact-us/partnerships/", "/contact-us/media-inquiries/", "/contact-us/worldwide-offices/", "https://twitter.com/PRNewswire", "https://www.facebook.com/PR-Newswire-26247320522/", "https://www.linkedin.com/company/pr-newswire/", "/products/communications-cloud/", "/products/marketing/", "/products/public-relations/", "/products/ir-compliance/", "/products/agency/", "https://www.smallbusinesspr.com/request_information", "/products/all-products/", "https://prnewswire.mediaroom.com/index.php", "https://www.cision.com/us/?utm_medium=website&utm_source=prnewswire&utm_content=cishomepage&utm_campaign=prnewswire", "/contact-us/prnewswire-partners/", "/contact-us/become-a-partner/", "https://www.cision.com/careers/", "https://www.cision.com/about/accessibility/", "https://www.prnasia.com/", "https://prnewswire.com.br/", "https://www.newswire.ca/", "/cs/tiskova-zprava/", "/da/pressemeddelelser/", "/fi/lehdistotiedotteet/", "/fr/communiques-de-presse/", "/de/pressemitteilungen/", "/in/news-releases/", "/il/news-releases/", "/it/comunicati-stampa/", "https://prnewswire.com.mx/", "/ae/news-releases/", "https://www.prnewswire.com/ae/ar/news-releases/", "/nl/persberichten/", "/no/pressemeldinger/", "/pl/komunikat-prasowy/", "/pt/comunicados-de-imprensa/", "/ru/press-releases/", "/sk/tlacova-sprava/", "/es/comunicados-de-prensa/", "/sv/pressmeddelanden/", "https://www.prnewswire.co.uk/", "/news-releases/", "https://portal.prnewswire.com/Login.aspx", "https://profnet.prnewswire.com/ProfNetHome/What-is-Profnet.aspx", "/contact-us", "/products/overview", "https://prnewswire.mediaroom.com/index.php", "", "/news-releases/", "https://portal.prnewswire.com/Login.aspx", "https://profnet.prnewswire.com/ProfNetHome/What-is-Profnet.aspx", "tel:Cision%20Distribution%20Helpline", "/terms-of-use/", "/privacy-policy/", "/prn-information-security-policy/", "/sitemap/", "/rss/", "/cookie-settings/", "https://www.cision.com/us/?utm_medium=website&utm_source=prnewswire&utm_content=cishomepage&utm_campaign=prnewswire", "javascript://Chat"]}